Prevalence and Associated Factors of Drug-Drug Interactions in Hospitalized Diabetic Patients: A Cross-Sectional Study
Main Article Content
Abstract
Diabetes mellitus is a chronic metabolic condition frequently associated with complications and comorbidities that often require hospitalization for effective management. Such patients are often prescribed multiple medications, which elevate the risk of potential drug-drug interactions (pDDIs). Hence, this study aims to determine the prevalence, severity, common interacting pairs, and factors associated with pDDIs among hospitalized diabetes patients. The study used a retrospective cross-sectional study design conducted at Universitas Indonesia Hospital. Lexicomp® Lexi-InteractTM software was used to analyze and classify possible drug interactions. Logistic regression analysis was used to identify different factors associated with potential DDIs. Of the 200 patients, 89.0% were observed to have pDDIs. A total of 966 interactions were found, of which 75.6% were moderate, 16.2% were minor, and 8.1% were of major severity. Meanwhile, in the risk rating C category, 71.0% were predominant, followed by B and D, 15.0% and 11.0%, respectively. Multivariate regression analysis showed a statistically significant association of pDDIs with 5–8 prescribed medicines (OR=22.8; 95% CI=5.5-94.7; p<0.001), >8 prescribed medicines (OR=64.4; 95% CI=11.3-336.5; p<0.001). The findings of this study revealed that pDDIs are highly prevalent in adult inpatients with diabetes. This emphasizes the critical need for appropriate monitoring and management strategies to reduce pDDIs and their adverse consequences.
Article Details
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The authors retain the copyright and grant the journal the right of first publication simultaneously under the Creative Commons Attribution License. This license allows others to share the work with proper acknowledgment of authorship and initial publication in this journal. Authors are permitted and encouraged to deposit their articles in institutional repositories, on their personal websites, or in other online repositories after the article has been published in JSFK.
References
. Aloke C, Egwu CO, Aja PM, Obasi NA, Chukwu J, Akumadu BO, et al. Current Advances in the Management of Diabetes Mellitus. Vol. 10, Biomedicines. MDPI; 2022. https://doi.org/10.3390/biomedicines10102436
. Kumar A, Gangwar R, Ahmad Zargar A, Kumar R, Sharma A. Prevalence of diabetes in India: A review of IDF diabetes atlas 10th edition. Curr Diabetes Rev. 2024;20(1):105–14.
. Oktora SI, Butar DB. Determinants of Diabetes Mellitus Prevalence in Indonesia. Jurnal Kesehatan Masyarakat. 2022;18(2):266–73.
. Linawati Y, Kristin E, Prabandari YS, Kristina SA. Exploring the experiences and needs of patients with type 2 diabetes mellitus in Sleman Regency, Yogyakarta, Indonesia: Protocol for a qualitative study. JMIR Res Protoc. 2022;11(9):e37528.
. Azam M, Sakinah LF, Kartasurya MI, Fibriana AI, Minuljo TT, Aljunid SM. Prevalence and determinants of obesity among individuals with diabetes in Indonesia. F1000Res. 2022;11:1063. https://doi.org/10.12688/f1000research.125549.1
. Matijević T, Talapko J, Meštrović T, Matijević M, Erić S, Erić I, et al. Understanding the multifaceted etiopathogenesis of foot complications in individuals with diabetes. World J Clin Cases. 2023;11(8):1669.
. Jenkins AJ. Adjunct Drug Treatment to Reduce Vascular Disease in People with Diabetes. In: Lipoproteins in Diabetes Mellitus. Springer; 2023. p. 779–819.
. Meir J, Huang L, Mahmood S, Whiteson H, Cohen S, Aronow WS. The vascular complications of diabetes: a review of their management, pathogenesis, and prevention. Expert Rev Endocrinol Metab. 2024;19(1):11–20.
. Bereda G. Risk Factors, Complications and Management of Diabetes Mellitus. Am J Biomed Sci Res. 2022;16(4):409–12. https://doi.org/10.34297/ajbsr.2022.16.002245
. Kumari S, Jain S, Kumar S. Effects of Polypharmacy in Elderly Diabetic Patients: A Review. Cureus. 2022; https://doi.org/10.7759/cureus.29068
. Alhumaidi RM, Bamagous GA, Alsanosi SM, Alqashqari HS, Qadhi RS, Alhindi YZ, et al. Risk of Polypharmacy and Its Outcome in Terms of Drug Interaction in an Elderly Population: A Retrospective Cross-Sectional Study. J Clin Med. 2023;12(12). https://doi.org/10.3390/jcm12123960
. Yu H, Li K, Shi J. DGANDDI: double generative adversarial networks for drug-drug interaction prediction. IEEE/ACM Trans Comput Biol Bioinform. 2022;
. Galetin A, Zhang L, Rodrigues AD, Huang S-M. Chapter 14 - Drug-drug interactions. In: Huang S-M, Lertora JJL, Vicini P, Atkinson AJ, editors. Atkinson’s Principles of Clinical Pharmacology (Fourth Edition). Boston: Academic Press; 2022. p. 241–65. https://doi.org/https://doi.org/10.1016/B978-0-12-819869-8.00013-6
. Očovská Z, Maříková M, Vlček J. Potentially clinically significant drug-drug interactions in older patients admitted to the hospital: A cross-sectional study. Front Pharmacol. 2023;14. https://doi.org/10.3389/fphar.2023.1088900
. Alili-Idrizi E, Saliu X, Ballazhi L, Haxhiu A, Havziu D, Sulejmani S. Evaluation of potential drug-drug interactions in inpatients treated at the internal ward. Acta Medica Balkanica-International Journal of Medical Sciences. 2022;7(13–14):55–62.
. Santos F, Sobreira A, Mota E, Paula D. Analysis of hospital admissions due to poisoning and adverse reactions to medicines in Rio de Janeiro (2014 to 2019). Concilium. 2023;23(14):184–96.
. De Oliveira LM, Diel JDAC, Nunes A, Da Silva Dal Pizzol T. Prevalence of drug interactions in hospitalised elderly patients: A systematic review. Vol. 28, European Journal of Hospital Pharmacy. BMJ Publishing Group; 2021. p. 4–9. https://doi.org/10.1136/ejhpharm-2019-002111
. Utami PR, Octavia DR. Study of potential interactions of oral antidiabetic drugs in patients with type 2 diabetes mellitus with comorbidities: A retrospective study. Pharmacy Education. 2022;22(2):200–6. https://doi.org/10.46542/pe.2022.222.200206
. Trevisan DD, Silva JB, Póvoa VC, Araujo CP, Oliveira HC, Araújo EP, et al. Prevalence and clinical significance of potential drug-drug interactions in diabetic patients attended in a tertiary care outpatient center, Brazil. Int J Diabetes Dev Ctries. 2016;36:283–9.
. Nusair MB, Al-Azzam SI, Arabyat RM, Amawi HA, Alzoubi KH, Rabah AA. The prevalence and severity of potential drug-drug interactions among adult polypharmacy patients at outpatient clinics in Jordan. Saudi Pharmaceutical Journal. 2020;28(2):155–60. https://doi.org/10.1016/j.jsps.2019.11.009
. Alhumaidi RM, Bamagous GA, Alsanosi SM, Alqashqari HS, Qadhi RS, Alhindi YZ, et al. Risk of Polypharmacy and Its Outcome in Terms of Drug Interaction in an Elderly Population: A Retrospective Cross-Sectional Study. J Clin Med. 2023;12(12). https://doi.org/10.3390/jcm12123960
. Samhitha Reddy Y, Somasekhar Reddy K. Prevalence and Risk Factors of Potential Drug-Drug Interactions in the In-Patient Medical Wards: A Hospital-Based Cross-Sectional Study. Int J Life Sci Pharma Res. 2022; https://doi.org/10.22376/ijpbs/lpr.2022.12.6.p250-256
. Perwirani R, Puspitasari I. Perancangan Clinical Decision Support System (CDSS) untuk Drug Drug Interaction (DDI) pada e-Prescription. JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice). 2023;12(4):198. https://doi.org/10.22146/jmpf.74506
. Patel RI, Beckett RD. Evaluation of resources for analyzing drug interactions. Journal of the Medical Library Association. 2016;104(4):290–5. https://doi.org/10.3163/1536-5050.104.4.007
. Lexicomp. Lexi-Interact [Internet]. Wolters Kluwer Health, Inc. 2024 [cited 2024 Apr 14]. Available from: https://online.lexi.com
. Roca B, Roca M. Assessment of Drug Interactions with Online Electronic Checkers in Multi-Pathological Patients. Pharmacology. 2022;107(1–2):111–5.
. Xiong G, Yang Z, Yi J, Wang N, Wang L, Zhu H, et al. DDInter: an online drug–drug interaction database towards improving clinical decision-making and patient safety. Nucleic Acids Res. 2022;50(D1):D1200–7.
. Kheshti R, Aalipour M, Namazi S. A comparison of five common drug–drug interaction software programs regarding accuracy and comprehensiveness. J Res Pharm Pract. 2016;5(4):257–63.
. Roosyidah FA, Yulia R, Herawati F, Wijono H. Drug Interactions in Diabetic Ulcer Patients in an Indonesian Private Hospital. Majalah Kedokteran Bandung. 2023;55(2):70–6. https://doi.org/10.15395/mkb.v55n2.2982
. Wittert G, Grossmann M. Obesity, type 2 diabetes, and testosterone in ageing men. Vol. 23, Reviews in Endocrine and Metabolic Disorders. Springer; 2022. p. 1233–42. https://doi.org/10.1007/s11154-022-09746-5
. Rawitri K, Wahyuni S, Sari SR. Analysis Of Potential Drug Interactions In Prescribing Type 2 Diabetes Mellitus Patients At A Pharmacy In Medan City [Internet]. International Journal of Health and Pharmaceutical. 2022. Available from: https://ijhp.net
. Sankar V, Saaed Y, Joseph R, Azizi H, Thomas P. Serious Drug-Drug Interactions in the Prescriptions of Diabetic Patients. Medical Sciences. 2015;3(4):93–103. https://doi.org/10.3390/medsci3040093
. Öksüz E, Buğday MS, Soyalp C, Karaaslan E, Oto G, Temelli Göçeroğlu R, et al. Drug-drug interactions in intensive care units and potential clinical consequences of these interactions. 2019;
. Noor S, Ismail M, Haider I, Khadim F. Drug-drug interactions in hepatitis patients: Do these interactions matter in clinical perspectives? Ann Hepatol. 2018;17(6):1001–11. https://doi.org/10.5604/01.3001.0012.2238
. Hasanloei V, Amin M, Hamdolah S, Aysa H. Drug–drug interactions prevalence in intensive care unit patients of a university hospital in Iran. Bulletin of Environment, Pharmacology and Life Sciences. 2014;3(7):87–91.
. Sankar V, Saaed Y, Joseph R, Azizi H, Thomas P. Serious Drug-Drug Interactions in the Prescriptions of Diabetic Patients. Medical Sciences. 2015;3(4):93–103. https://doi.org/10.3390/medsci3040093
. Kalash A, Abdelrahman A, Al-Zakwani I, Al Suleimani Y. Potentially Harmful Drug–Drug Interactions and Their Associated Factors Among Hospitalized Cardiac Patients: A Cross-Sectional Study. Drugs Real World Outcomes. 2023;10(3):371–81. https://doi.org/10.1007/s40801-023-00373-3
. Noor S, Ismail M, Khadim F. Potential drug-drug interactions associated with adverse clinical outcomes and abnormal laboratory findings in patients with malaria. Malar J. 2020;19(1). https://doi.org/10.1186/s12936-020-03392-5
. Hatefi S, Kadkhodaei A, Nejati B, Ghaffary S. Evaluation of Drug Interactions in Hospitalized Patients with Malignancy. Int J Hematol Oncol Stem Cell Res. 2022;16(4):224.
. Santos-Díaz G, Pérez-Pico AM, Suárez-Santisteban MÁ, García-Bernalt V, Mayordomo R, Dorado P. Prevalence of potential drug–drug interaction risk among chronic kidney disease patients in a spanish hospital. Pharmaceutics. 2020;12(8):1–11. https://doi.org/10.3390/pharmaceutics12080713
. Yanti E, Kristin E-, Yasmina A. Potential drug interactions in hypertensive patients in Liwa District Hospital, Lampung Barat, Indonesia. Int J Pharm Pharm Sci. 2017;9(6):134. https://doi.org/10.22159/ijpps.2017v9i6.18003
. Ramadhani P, Fauziah F, Kurnia NM. Polypharmacy and Drug Interactions in Geriatric Patients with Type 2 Diabetes Mellitus at the Internal Medicine Inpatient Installation at RSUP Dr. M. Djamil Padang. International Journal of Pharmaceutical Sciences and Medicine. 2023;8(5):1–6. https://doi.org/10.47760/ijpsm.2023.v08i05.001
. Sankar V, Parthasarathy R, Jerrin M. A prospective interventional study on comorbidities, drug – drug interactions and its management among cancer patients. Ars Phamaceutica. 2019; https://doi.org/10.30827/ARS.V61I2.10286
. Lule AP, Delic OB, Katunguka K, Muwonge F, Yadesa TM. Prevalence and factors associated with potential drug-drug interactions in prescriptions presented at private pharmacies in Mbarara city, southwestern Uganda. BMC Pharmacol Toxicol. 2024;25(1):2.
. Sahoo AK, Gupta D. A Study of Clinically Signicant Potential drug-drug Interactions and their Risk Factors among Hospitalized Cardiac patients. 2023; https://doi.org/10.21203/rs.3.rs-2727312/v1
. Očovská Z, Maříková M, Vlček J. Potentially clinically significant drug-drug interactions in older patients admitted to the hospital: A cross-sectional study. Front Pharmacol. 2023;14. https://doi.org/10.3389/fphar.2023.1088900
. Liu Y, Wang J, Gong H, Li C, Wu J, Xia T, et al. Prevalence and associated factors of drug-drug interactions in elderly outpatients in a tertiary care hospital: a cross-sectional study based on three databases. Ann Transl Med. 2023;11(1):17–17. https://doi.org/10.21037/atm-22-5463
. Anfinogenova ND, Novikova OM, Trubacheva IA, Efimova E V, Chesalov NP, Ussov WY, et al. Prescribed-vs.-Taken Polypharmacy and Drug-Drug Interactions in Older Cardiovascular Patients: Observational Cross-Sectional Analytical Study. 2023; https://doi.org/10.20944/preprints202306.1998.v1
. Altunal LN, Yagcı Caglayık D, Ozel AS, Tukenmez Tigen E, Sili U, Erturk Sengel B, et al. Prevalence of Polypharmacy and Potential Drug–Drug Interactions Associated with Risk Factors in the Era of HIV Integrase Inhibitors: A Prospective Clinical Study. AIDS Patient Care STDS. 2023;37(3):138–45.
. Lalatović N, Pantović S, Nedović-Vuković M, Kostić M. Risk Factors for Potential Drug-Drug Interactions in Outpatients with Dyslipidemia. Iran J Public Health. 2023;52(7):1466.
. Rasool MF, ur Rehman A, Khan I, Latif M, Ahmad I, Shakeel S, et al. Assessment of risk factors associated with potential drug-drug interactions among patients suffering from chronic disorders. PLoS One. 2023;18(1 January). https://doi.org/10.1371/journal.pone.0276277
. Hassan KAM, Mudawi MME, Sulaiman MI. Pharmacodynamics drug interactions of metformin with aspirin and nifedipine. Asian Journal of Pharmaceutical Research and Health Care. 2016;8(1):4–10. https://doi.org/10.18311/ajprhc/2016/683
. Orchard SG, Lockery JE, Broder JC, Ernst ME, Espinoza S, Gibbs P, et al. Association of metformin, aspirin, and cancer incidence with mortality risk in adults with diabetes. JNCI Cancer Spectr. 2023;7(2). https://doi.org/10.1093/jncics/pkad017
. Bajracharya N, Swaroop AM, Rajalekshmi SG, Viswam SK, Maheswari E. Incidence of drug-drug interactions among patients admitted to the department of general medicine in a tertiary care hospital. Journal of Young Pharmacists. 2018;10(4):450.